Authors


Ernesto Chico

Latest:

Manufacturing Process Development for an Epidermal Growth Factor-Based Cancer Vaccine

The Center for Molecular Immunology (Havana, Cuba) has been working on a novel cancer immunotherapy targeting the epidermal growth factor (EGF). The vaccine is composed of a chemical conjugate of EGF and a carrier protein (rP64k), designed to trigger an anti-EGF antibody response. The results of studies of molecular characterization, immunogenic activity, and clinical data are presented here.


Pauline Farmer-Koppenol

Latest:

Protecting Patents for Personalized Medicine

There are several challenges associated with protecting patents for personalized medicines.


Loany Calvo

Latest:

Manufacturing Process Development for an Epidermal Growth Factor-Based Cancer Vaccine

The Center for Molecular Immunology (Havana, Cuba) has been working on a novel cancer immunotherapy targeting the epidermal growth factor (EGF). The vaccine is composed of a chemical conjugate of EGF and a carrier protein (rP64k), designed to trigger an anti-EGF antibody response. The results of studies of molecular characterization, immunogenic activity, and clinical data are presented here.


Dattananda Chelur

Latest:

Fusion Tags for Protein Expression and Purification

Gene fusion tags can improve the yield and solubility of many recombinant proteins. This article discusses the most popular fusion tags and the proteases used to remove them, with special reference to recently introduced technologies.



Bas Kremer, PhD

Latest:

Advances in Single-Shot Vaccine Development

The disadvantages of the traditional vaccine regime (prime plus boost) have spurred the development of single-shot vaccines. This article describes the development and manufacture of a prototype single-shot vaccine that uses microspheres made from cross-linked modified dextran polymers for controlled release of the antigen.


Bob Bader

Latest:

Lifecycle Cost Analysis for Single-Use Systems

This article describes a quick method for evaluating lifecycle costs for single-use systems against their more conventional stainless-steel counterparts.


Robin Robinett

Latest:

Integrating CMC Document Preparation into the Development Process for Vaccine INDs

Vaccine process development is complex, and so are the documents required before clinical trials begin. Technical writers and editors can effectively coordinate the timely authoring, reviewing, and auditing of regulatory documents, minimizing filing delays.






Stacey Cox

Latest:

The Environmental Impact of Disposable Technologies

Can disposables reduce your facility's environmental footprint? We have compared the environmental footprint of a traditional biopharmaceutical manufacturing facility using fixed-in-place stainless steel equipment, and a facility implementing disposable technologies for cell culture, solution mixing and hold, product hold, and liquid transfer.



Mark Watkins-Fischl

Latest:

Optimizing the Primary Recovery Step in Nonaffinity Purification Schemes for HuMAbs

An alternative approach to traditional Protein A schemes is comparable in overall efficiency, product recovery, and quality.


Lindsay Leveen

Latest:

The Environmental Impact of Disposable Technologies

Can disposables reduce your facility's environmental footprint? We have compared the environmental footprint of a traditional biopharmaceutical manufacturing facility using fixed-in-place stainless steel equipment, and a facility implementing disposable technologies for cell culture, solution mixing and hold, product hold, and liquid transfer.



Ken Green

Latest:

Challenging the Cleanroom Paradigm for Biopharmaceutical Manufacturing of Bulk Drug Substances

The authors re-examine environmental controls in the context of technical advances in manufacturing.



Martha Pupo

Latest:

The Purification of Plasmid DNA for Clinical Trials Using Membrane Chromatography

Membrane chromatography ensures purity at high flow rates.


Gopinath Annathur

Latest:

The Development and Application of a Monoclonal Antibody Purification Platform

A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.



Miladys Limonta Fernández

Latest:

Scale up of Fed-Batch Culture to Produce Plasmid DNA in Escherichia coli (Peer Reviewed)

The authors present scale-up from a 5-L fermentor to a 50-L pilot-scale using the criterion of constant power consumption per unit liquid volume.


Airama Albisa

Latest:

Manufacturing Process Development for an Epidermal Growth Factor-Based Cancer Vaccine

The Center for Molecular Immunology (Havana, Cuba) has been working on a novel cancer immunotherapy targeting the epidermal growth factor (EGF). The vaccine is composed of a chemical conjugate of EGF and a carrier protein (rP64k), designed to trigger an anti-EGF antibody response. The results of studies of molecular characterization, immunogenic activity, and clinical data are presented here.


Timothy Pabst, PhD

Latest:

The Development and Application of a Monoclonal Antibody Purification Platform

A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.



Faiz Kermani, PhD

Latest:

India's Clinical Trials Market Accelerates

Most local and global clinical research organizations (CROs) consider an operational presence in India as key to their overall business plans. India is clearly on course to become the next hub for clinical trials.


Leo de Leede

Latest:

Advances in Single-Shot Vaccine Development

The disadvantages of the traditional vaccine regime (prime plus boost) have spurred the development of single-shot vaccines. This article describes the development and manufacture of a prototype single-shot vaccine that uses microspheres made from cross-linked modified dextran polymers for controlled release of the antigen.


Roberta Morris

Latest:

Disposables for Bioprocessing: Making the Transition

Transitioning from stainless steel technology to disposable technology in bioprocessing.


Bill Brune

Latest:

Maximizing Yields of Plasmid DNA Processes

Recombinant protein and plasmid DNA production using microbial expression systems is the cornerstone of many biologics manufacturing processes. HCD methods are commonly used for these processes because of the advantages they provide.

© 2024 MJH Life Sciences

All rights reserved.